Chapters

Transcript

Video

Can you summarize the design of the ARTISTRY-1 trial with nemvaleukin, including strategies/phases incorporated to evaluate the potential effectiveness, dosing, and combinatorial effects of nemvaleukin with ICIs in the setting of solid tumors?


Created by

CMEducation Resources | iQ&A Cytokine Immunotherapy Intelligence Zone

Presenter

Ulka Vaishampayan, MBBS

Ulka Vaishampayan, MBBS

Professor of Internal MedicineDirector, Phase I ProgramRogel Cancer CenterUniversity of MichiganAnn Arbor, MI